rs138958917
Variant summary
Our verdict is Pathogenic. The variant received 15 ACMG points: 15P and 0B. PM5PP2PP3_StrongPP5_Very_Strong
The NM_001298.3(CNGA3):c.667C>G(p.Arg223Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000013 in 1,461,402 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R223Q) has been classified as Likely pathogenic.
Frequency
Consequence
NM_001298.3 missense
Scores
Clinical Significance
Conservation
Publications
- achromatopsia 2Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Illumina, PanelApp Australia
- CNGA3-related retinopathyInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- cone-rod dystrophyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- achromatopsiaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 15 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CNGA3 | ENST00000272602.7 | c.667C>G | p.Arg223Gly | missense_variant | Exon 7 of 8 | 1 | NM_001298.3 | ENSP00000272602.2 | ||
| CNGA3 | ENST00000436404.6 | c.613C>G | p.Arg205Gly | missense_variant | Exon 6 of 7 | 1 | ENSP00000410070.2 | |||
| CNGA3 | ENST00000409937.1 | n.820C>G | non_coding_transcript_exon_variant | Exon 7 of 8 | 2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.0000358 AC: 9AN: 251150 AF XY: 0.0000295 show subpopulations
GnomAD4 exome AF: 0.0000130 AC: 19AN: 1461402Hom.: 0 Cov.: 31 AF XY: 0.0000124 AC XY: 9AN XY: 727028 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Achromatopsia 2 Pathogenic:1
Variant summary: CNGA3 c.667C>G (p.Arg223Gly) results in a non-conservative amino acid change located in the Ion transport domain (IPR005821) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 3.6e-05 in 251150 control chromosomes. c.667C>G has been observed in a compound heterozygous individual affected with Achromatopsia 2 (Wiszniewski_2007). It has also been reported in two Jewish individuals with inherited retinal diseases without clarification of the second allele variants (Sharon_2020). At least one publication reports experimental evidence evaluating an impact on protein function. The most pronounced variant effect results in <10% of normal activity (Solaki_2023). The following publications have been ascertained in the context of this evaluation (PMID: 31456290, 37689994, 17265047). ClinVar contains an entry for this variant (Variation ID: 812278). Based on the evidence outlined above, the variant was classified as pathogenic. -
Achromatopsia Pathogenic:1
- -
Inborn genetic diseases Pathogenic:1
The c.667C>G (p.R223G) alteration is located in exon 7 (coding exon 6) of the CNGA3 gene. This alteration results from a C to G substitution at nucleotide position 667, causing the arginine (R) at amino acid position 223 to be replaced by a glycine (G). Based on data from gnomAD, the G allele has an overall frequency of <0.01% (9/251150) total alleles studied. The highest observed frequency was 0.09% (9/10080) of Ashkenazi Jewish alleles. This alteration has been reported in a patient with achromatopsia in combination with a second CNGA3 alteration (Wiszniewski, 2007). Two alterations affecting the same amino acid, p.R223W and p.R223Q, have also been reported in association with achromatopsia (Wissinger, 2001; Fahim, 2013; Greenberg, 2014; Li, 2014). This amino acid position is not well conserved in available vertebrate species. This alteration is predicted to be deleterious by in silico analysis. Based on the available evidence, this alteration is classified as likely pathogenic. -
not provided Pathogenic:1
This sequence change replaces arginine, which is basic and polar, with glycine, which is neutral and non-polar, at codon 223 of the CNGA3 protein (p.Arg223Gly). This variant is present in population databases (rs138958917, gnomAD 0.08%). This missense change has been observed in individual(s) with achromatopsia (PMID: 17265047, 31456290; internal data). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 812278). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed for this missense variant. However, the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on CNGA3 protein function. This variant disrupts the p.Arg223 amino acid residue in CNGA3. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 11536077, 23972307). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at